SEC Form 4 · accession 0000899243-16-023407
Invuity, Inc. · IVTY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric W Roberts
Director
Period of report
Jun 19, 2016
Accepted (ET)
Jun 21, 2016 · 8:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393020
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 19, 2016 | M | 12,800 | — | A | 76,945 | D | |
| Common StockF2 | holding | — | — | — | 326,086 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jun 19, 2016 | M | 12,800 | D | Jun 19, 2016 | Jun 19, 2016 | Common Stock | 12,800 | 0 | D |
Explanation of responses
- F1Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
- F2The shares are held by Valence CDK SPV, L.P. ("Valence CDK"). Valence Life Sciences GP II, LLC ("Valence") is the General Partner of Valence CDK. The Reporting Person is a Managing Member of Valence and disclaims beneficial ownership of the shares held by Valence CDK, except to the extent of his pecuniary interest therein.
- F3The Form 4 filed on May 23, 2016 lists June 18, 2016 as the vesting and expiration dates of the RSUs; the vesting and expiration dates are actually June 19, 2016.